Friday, 10 January 2025

GSR 220 cancellation request

कोरोना काल में दवा बिक्री को लेकर जारी अधिसूचना को रद्द करे सरकार

भागलपुर केमिस्ट एंड ड्रगिस्ट एसोसिएशन के महासचिव प्रशांत लाल ठाकुर ने कोरोना संक्रमण को रोकने के लिए जारी अधिसूचना जीएसआर 220 (ई) को रद्द करने की मांग की है। उनका कहना है कि डिजिटल प्लेटफार्म बिना वैध..

भागलपुर, वरीय संवाददाता कोरोना संक्रमण को रोकने के लिए दवा बिक्री को लेकर जारी अधिसूचना जीएसआर 220 (ई) को भागलपुर केमिस्ट एंड ड्रगिस्ट एसोसिएशन के महासचिव प्रशांत लाल ठाकुर ने रद्द किए जाने की मांग की है। उन्होंने कहा कि ये अधिसूचना कोरोना काल में स्थानीय दवा विक्रेताओं को इमरजेंसी के आधार पर स्थानीय दवा दुकानदारों को घर-घर दवा पहुंचाने की सुविधा देने के लिहाज से जारी की गई थी। लेकिन मौजूदा काल में कई डिजिटल प्लेटफार्म इस अधिसूचना का दुरुपयोग कर बिना किसी वैध प्रिस्क्रिप्शन के घर-घर दवाई पहुंचा रहे हैं। जो रोगाणुरोधी प्रतिरोध, नशीली दवाओं के दुरुपयोग और स्वचिकित्सा जैसी समस्याओं को जन्म दे सकती है। ऑनलाइन दवा बेच रहे प्लेटफार्म का ध्यान केवल उनके अपने मुनाफे पर है। यदि इस अधिसूचना पर रोक नहीं लगती है तो ये ऑनलाइन कारोबार जनता की सेहत के लिए खतरे का सबब बन सकता है। ऐसे में इस अधिसूचना को रद्द कर दवाओं की बिक्री और वितरण के लिए प्रिस्क्रिप्शन और अन्य नियामक प्रावधानों का कड़ाई से पालन कराया जाय. 


Protect your Pharmacist

Physicians are well protected by their own folks.

They are 'No Wrong Doers'!

Who should protect the Pharmacists in the service and in the Regulatory?

#RegulatoryOfficersAssociation
#IPA
#IHPA
#APTI
#AIOCD
#PharmacistsAssociation

Tuesday, 7 January 2025

Reality against Myths (PCI book)😢What PCI has to say?

Reality against Myths (PCI book)😢

What PCI has to say? 

Drugs Control officers can not take action for non compliance with  PPR or Pharmacy Act. 

Incidentally, the term " Pharmacy" contemplated under Rule 65(15)(c) refers to establishments complying with Schedule N of Drugs and Cosmetics Rules. For records, establishments possessing license for " Pharmacy" in compliance with Schedule N is in single digits, may be TWO or THREE in the entire State of Karnataka. Even these two or three need not comply with PPR. They have to comply with Schedule N.

Let me also clarify that the medical shops where D.Pharm holders are engaged and whose number in the State is more than 30000 and for whose upliftment you are fighting for are referred as " Chemists and Druggists " under Rule 65(15)(c).
 
I have been saying PPR has no legal sanctity. None has bothered to look into this and everyone harps on implementing PPR.  

Lastly, :

1. To implement SECTION 42 of Pharmacy Act separate authority is contemplated. State Councils are accountable if they have not appointed inspectors to implement Section 42 for decades.

2. Your observation Drugs regulatory together with State pharmacy Council can make the system water tight for violators is a wishful thinking."...
Unquote:
... 😢
Attn:#PCI
This has happend is happening because:
1.PCI administrators do not know how to administer the office.
2. PCI do not follow Government Office Manual and PCI is being managed without due documentation and #Accountability, otherwise how the President's resignation letter was accepted without scrutiny and someone takes over without any fuss.
4.PCI is playing irresponsibly with the life of millions of youngsters leaving them Blindfold!
5. PCI is  luxurious jambooree to the members to make family trips.

Poor pharmacists 😢

POV : Bhagwan PS


Saturday, 4 January 2025

Mohalla Clinic

A Mohalla Clinic is a primary health center in India that offers free essential health services to the community: 
  • Services: Free consultations, diagnostics, and medicines
  • Location: Located within a kilometer of the patient's home 
  • Purpose: To reduce the financial burden on low-income households by providing free healthcare and saving travel costs 
  • Name: The word mohalla in Hindi means "neighborhood" or "community"

Sch K amendment - Has these Objectives been Achieved?

Sch K amendment - Has these Objectives been Achieved?

The amendments to Schedule K of the Drugs and Cosmetics Rules, 1945, introduced significant changes to streamline drug regulations and accessibility. Here’s a comparative summary of the situation before and after the amendment:

👉Before the Amendment

1. Applicability and Scope:

Schedule K exempted certain classes of drugs and circumstances from specific provisions of the Drugs and Cosmetics Act, such as licensing requirements.

Focused primarily on traditional practices like home remedies, medicines for medical professionals' personal use, and drugs distributed under government programs.

2. Community Pharmacist Role:

Limited emphasis on the active role of community pharmacists in drug dispensing.

Drugs like antimalarials, contraceptives, and certain public health program-related medications were exempt from licensing under specific distribution schemes.

3. Challenges:

Regulatory gaps led to potential misuse and lack of uniformity in drug dispensing.

Limited coverage for modern healthcare needs.

The evolving role of pharmacists was not well-integrated.

👉After the Amendment

1. Expanded Scope and Clarity:

The amended Schedule K included clearer definitions and expanded exemptions to include new healthcare settings, such as telemedicine, e-pharmacies, or alternative delivery mechanisms.

Streamlined processes for government health programs.

2. Enhanced Role of Pharmacists:

Stronger emphasis on the role of qualified pharmacists in dispensing drugs exempted under Schedule K.

More robust inclusion of community pharmacists to bridge healthcare access gaps.

3. Strengthened Public Health Initiatives:

👉Better alignment with national health priorities, including immunization, TB control, and other public health programs.

Rationalized exemptions for drugs used in specific national healthcare programs, reducing regulatory delays.

4. Digital and Telemedicine Integration:

Eased rules for modern dispensing methods, recognizing the role of digital healthcare and online pharmacies in delivering medicines, especially in remote areas.

5. Regulatory Compliance:

👉Tighter monitoring of exempted drug categories to reduce misuse or diversion.

Improved documentation and accountability measures.

👉Impact of the Amendment

Improved Accessibility: Rural and underserved regions benefited from greater accessibility to essential medicines without unnecessary bureaucratic hurdles.

Pharmacist Empowerment: Elevated pharmacists’ status as critical stakeholders in ensuring safe drug delivery and patient counseling.

Adaptation to Modern Healthcare Needs: Regulatory provisions evolved to accommodate digital healthcare platforms, telemedicine, and innovations in drug distribution.

These changes have harmonized regulations with the dynamic healthcare landscape while ensuring public safety and enhancing pharmacists' contributions to patient care.

Has this not made 'Pharmacist' dispensable/Replaceable and Substitutable?

PCI has a right to verify and demand reversal if it is found curtailing the scope of the profession and professionals

POV : Bhagwan PS

Saturday, 28 December 2024

Pharm D course introduction and D Pharma course closure is Propaganda !!!

I don't understand why D. Pharma course is being removed as minimum qualification for registration to practice Pharmacy in India. 

They say due to corruption. (Propaganda)

But I have seen corruption and malpractices happening at higher education level as well. 

1)PhD and PharmD students/interns publishing their names in scientific journals for research articles in which they have not done anything and just paid asked amount to the principal researcher so that their name get added in the research article as co-authors or co-researchers for publishing in scientific journals.

2)illogical sequence of subjects taught at colleges with these newly started courses.

3)Renting of license will continue even on Pharm-D ( doctor of pharmacy) degree.

4)To make minimum qualification for a registered pharmacist to do pharmacy practice in India, Pharm-D degree rather than D.Pharm ie. to replace the state's diploma of pharmacist.

Instead of updating and upgrading the syllabus of D.Pharm, what the policy makers have done is that they have created a new course named Pharm.D/Pharmd(PB) and obvious plan is to make it the minimum qualification for a registered pharmacist to do pharmacy practice in India.

Why create so much confusion, why malign the integrity of Pharmacy field. They could have retained the D.Pharm course and should have made neccessary changes in the syllabus and duration of D.Pharm, so that the minimum qualification for a registered pharmacist to do pharmacy practice in India remain D.Pharm and no need to replace the state's diploma of pharmacist. 

Just imagine if M.B.B.S course is replaced by some other course which is made minimum qualification for a registered physician to do medical practice in India.

And then they call themselves Pharma Expert or Drug Expert. What a pity situation ?

Friday, 20 December 2024

Routine checks for spurious drugs by drug inspectors

Routine checks for spurious drugs by drug inspectors from the desk of
Drugs Control Department
Karnataka 

https://chat.whatsapp.com/IECdk7yCsmJ9kSNOo7Tx0k
Inspections conducted by drug inspectors often reveal whether a medicine is spurious or misbranded through rigorous sampling and laboratory testing.
during routine checks at manufacturing units, pharmacies or distribution channels, inspectors collect samples of medicines, which are sent to government-approved laboratories for analysis.

“If a medicine fails to meet the prescribed quality standards set by regulatory authorities such as the Drugs Controller General of India (DCGI), contains incorrect or harmful ingredients, or is falsely labelled, it is classified as spurious. Similarly, if the labelling is inaccurate, misleading or fails to adhere to regulatory guidelines, the medicine is marked as misbranded. Once identified, the drugs are labelled accordingly, and immediate action is taken to prevent their distribution and sale,” the official said.
https://chat.whatsapp.com/IECdk7yCsmJ9kSNOo7Tx0k
These medicines pose significant risks to public health as they can lead to ineffective treatment, adverse reactions and harm antibiotic resistance, the official said, adding that regulatory authorities, on a regular basis, detect spurious or misbranded medicines through inspections, testing, consumer complaints, and monitoring of manufacturing processes.